- Home
- UNCY vs BRAG Comparison
UNCY vs BRAG Comparison
Compare UNCY & BRAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- BRAG
- Stock Information
- Founded
- UNCY 2016
- BRAG 2018
- Country
- UNCY United States
- BRAG Canada
- Employees
- UNCY N/A
- BRAG N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- BRAG Office Equipment/Supplies/Services
- Sector
- UNCY Health Care
- BRAG Technology
- Exchange
- UNCY Nasdaq
- BRAG Nasdaq
- Market Cap
- UNCY 74.2M
- BRAG 74.8M
- IPO Year
- UNCY 2021
- BRAG N/A
- Fundamental
- Price
- UNCY $4.93
- BRAG $2.85
- Analyst Decision
- UNCY Strong Buy
- BRAG Buy
- Analyst Count
- UNCY 5
- BRAG 4
- Target Price
- UNCY $55.20
- BRAG $7.00
- AVG Volume (30 Days)
- UNCY 419.1K
- BRAG 54.3K
- Earning Date
- UNCY 11-12-2025
- BRAG 11-13-2025
- Dividend Yield
- UNCY N/A
- BRAG N/A
- EPS Growth
- UNCY N/A
- BRAG N/A
- EPS
- UNCY N/A
- BRAG N/A
- Revenue
- UNCY N/A
- BRAG $123,209,630.00
- Revenue This Year
- UNCY N/A
- BRAG $6.62
- Revenue Next Year
- UNCY $19,912.34
- BRAG $5.85
- P/E Ratio
- UNCY N/A
- BRAG N/A
- Revenue Growth
- UNCY N/A
- BRAG 10.90
- 52 Week Low
- UNCY $3.71
- BRAG $2.59
- 52 Week High
- UNCY $11.00
- BRAG $6.12
- Technical
- Relative Strength Index (RSI)
- UNCY 66.90
- BRAG 45.68
- Support Level
- UNCY $4.33
- BRAG $2.84
- Resistance Level
- UNCY $4.81
- BRAG $2.95
- Average True Range (ATR)
- UNCY 0.31
- BRAG 0.14
- MACD
- UNCY 0.04
- BRAG 0.01
- Stochastic Oscillator
- UNCY 70.07
- BRAG 15.48
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.